Zobrazeno 1 - 7
of 7
pro vyhledávání: '"R Medina Comas"'
Autor:
C Redondo Galán, R Medina Comas, Rivas Rodríguez, M Ferris Villanueva, D Gonzalez Vaquero, JF Rangel Mayoral
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance With the arrival of the global SARS-CoV-2 pandemic, hospital pharmacy services (HPS) have had to adapt to emerging needs. One of these measures has been the sending of medicines to vulnerable patients who, due to their patho
Autor:
C Bonilla Galán, Y Gonzalez Gudiño, C Meneses Mangas, S Martín Clavo, LM Bravo García-Cuevas, R Medina Comas, JF Rangel Mayoral, E Garcia Lobato, D Briegas Morera
Publikováno v:
Clinical pharmacy.
Background The antiretroviral combination tenofovir disoproxil, emtricitabine, cobicistat and elvitegravir (TDF/FTC/COBI/RVG) has been widely used to treat HIV infection. This regimen is related to the highest risk of kidney disease because of the ab
Autor:
E Garcia Lobato, JF Rangel Mayoral, LM Bravo García-Cuevas, C Meneses Mangas, P Guillen Alvarez, D Briegas Morera, R Medina Comas, S Martín Clavo
Publikováno v:
Clinical pharmacy.
Background Afatinib is a second generation irreversible EGFR tyrosine kinase inhibitor (TKI), indicated as firstline therapy in non-small cell lung cancer (NSCLC). There are two other first generation EGFR TKIs indicated in NSCLC treatment, and no di
Autor:
E Garcia Lobato, J Pardal, S Martín Clavo, JF Rangel Mayoral, D Briegas Morera, C Meneses Mangas, LM Bravo García-Cuevas, C Bonilla Galán, R Medina Comas
Publikováno v:
Drug information and pharmacotherapy.
Background Despite living in the high tech era, there is still a lack of software tools to help pharmacists to carry out their common tasks, pharmaceutical care being one of the most important. Purpose Designing a friendly intuitive application to ga
Autor:
C Bonilla Galán, J Groiss Buiza, J Liso Rubio, S Martín Clavo, LM Bravo García-Cuevas, L Romero Soria, R Medina Comas, D Briegas Morera, JF Rangel Mayoral, C Meneses Mangas
Publikováno v:
European Journal of Hospital Pharmacy. 22:A88.1-A88
Background Aplastic anaemia comes from a bone marrow failure which affects all blood lineages. Treatment is based on immunosuppression or allogeneic transplant, but some patients are refractory to these options. Eltrombopag, a thrombopoietin receptor
Autor:
C Bonilla Galán, L Romero Soria, D Briegas Morera, C Meneses Mangas, JF Rangel Mayoral, LM Bravo García-Cuevas, S Martín Clavo, R Medina Comas
Publikováno v:
European Journal of Hospital Pharmacy. 22:A14.3-A15
Background Drugs interact when the effect of a drug is modified by another co-administered drug, food or herb. According to a number of studies, almost half the prescriptions are accompanied by interactions (8–43%, depending on the ward), but few (
Autor:
R Medina Comas, L Romero Soria, S Martín Clavo, JF Rangel Mayoral, P Gemio Zumalave, M.J. Izquierdo Pajuelo, J.L. Braga Fuentes, LM Bravo García-Cuevas, MJ Estepa Alonso, M.S. Rivero Cava
Publikováno v:
European Journal of Hospital Pharmacy. 19:129.2-129
Background Treatment with bortezomib is frequently associated with haematological toxicity. In addition infrequent gastrointestinal disorders such as ischaemic colitis, irritable bowel syndrome and paralytic ileus are described, among others. Purpose